Raf Kinase inhibitor protein: mechanism of loss of expression and association with genomic instability

F. Al-Mulla, Suzanne Hagan, W. Al-Ali, A. I. Behbehani, M. S. Bitar, A. Dallol, W. Kolch

Research output: Contribution to journal › Article › peer-review

76 Citations (Scopus)

Filter

2015
EPMA position paper in cancer: current overview and future perspectives
Grech, G., Zhan, X., Yoo, B. C., Bubnov, R., Hagan, S., Danesi, R., Vittadini, G. & Desiderio, D. M., 15 Apr 2015, In: EPMA Journal. 6, 1, p. 9-39 31 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
78 Citations (Scopus)

88 Downloads (Pure)
2013
Targeted therapies in colorectal cancer: an integrative view by PPPM
Hagan, S., Orr, M. C. M. & Doyle, B., Dec 2013, EPMA Journal, 4, 3, p. 3-18 16 p.
Research output: Contribution to specialist publication › Article

Open Access
File
60 Citations (Scopus)

63 Downloads (Pure)
2007
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W., May 2007, In: Oncogene. 26, 22, p. 3279-3290 12 p.
Research output: Contribution to journal › Article › peer-review
2005 Citations (Scopus)
2006
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients
Al-Mulla, F., Hagan, S., Behbehani, A. I., Bitar, M. S., George, S. S., Going, J. J., Curto Garcia, J. J., Scott, L., Fyfe, N., Murray, G. I. & Kolch, W., Dec 2006, In: Journal of Clinical Oncology. 24, 36, p. 5672-5679 8 p.
Research output: Contribution to journal › Article › peer-review
167 Citations (Scopus)

Research output